Tezacitabine
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111657This classification denotes a ribonucleotide reductase inhibitor and pyrimidine antagonist with the molecular formula C10H12FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7607Y95N9S, chemically known as mdl 101,731 but generally known as tezacitabine, which bears US NIH Compound Identifier 6435808. The term TEZACITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). Most nations schedule tezacitabine under HS 29349990 and SITC 51579. As of Q4 2014, TEZACITABINE remains the US FDA Preferred Term for this commodity. Tezacitabine bears US NLM identifiers UMLS ID C0253087 and NCI Concept Code C1539. SMILES: C1=CN(C(=O)N=C1N)C2C(=CF)C(C(O2)CO)O.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.